Aethlon Medical, Inc. (AEMD)
-OTC BB 0.11 
0.00(0.18%) May 17, 3:59PM EDT
| Prev Close: | 0.11 |
|---|
| Open: | 0.11 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 1.00 |
|---|
| Beta: | 1.83 |
|---|
| Next Earnings Date: | 28-Jun-13 |
|---|
| Day's Range: | 0.10 - 0.11 |
|---|
| 52wk Range: | 0.06 - 0.15 |
|---|
| Volume: | 117,473 |
|---|
| Avg Vol (3m): | 325,132 |
|---|
| Market Cap: | 18.49M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.05 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Aethlon Medical (AEMD) Note: An Update on the Clinical Status of the Aethlon Hemopurifier® in Hepatitis-C CarePR Newswire(Tue, May 7)
- Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013PR Newswire(Thu, Apr 18)
- Aethlon Medical (AEMD) Note: New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President ObamaPR Newswire(Tue, Apr 16)
- AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Mon, Apr 15)
- WellCare to join Georgia TeleHealthZacks(Thu, Mar 7)
- How Cancer Beats the Immune SystemAccesswire(Thu, Mar 7)
- Humana Reiterated NeutralZacks(Wed, Mar 6)
- REIT Companies Join to Webcast Live for Special March 7th RetailInvestorConferences.com EventCNW Group(Tue, Mar 5)
- REIT Companies Join to Webcast Live for Special March 7th RetailInvestorConferences.com EventPR Newswire(Tue, Mar 5)
- Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & CancerPR Newswire(Thu, Feb 28)
- Are Exosomes the Key to Stopping the Spread of Cancer?Accesswire(Wed, Feb 27)
- AETHLON MEDICAL INC FinancialsEDGAR Online Financials(Thu, Feb 21)
- AEMD: DAPRA Revenue, Operational Progress ContinuesZacks(Thu, Feb 14)
- AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, Feb 12)
- Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.comPR Newswire(Mon, Feb 11)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 15.04 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Mar-13)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Aethlon Medical, Inc., a development stage medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions.
View More